Ultragenyx Pharmaceutical Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 02/11/2025 | 10.03 M | $422.17 M | 0.90% | 10.51% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 6.54 M | $274.99 M | 12.14% | 6.85% |
| SANDS CAPITAL MANAGEMENT, LLC | 02/13/2025 | 4.30 M | $180.82 M | -16.03% | 4.50% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 2.51 M | $105.70 M | -18.13% | 2.63% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 2.46 M | $103.39 M | -41.00% | 2.57% |
| CLEARBRIDGE INVESTMENTS, LLC | 02/12/2025 | 2.32 M | $97.70 M | -4.32% | 2.43% |
| FEDERATED HERMES, INC. | 02/13/2025 | 2.05 M | $86.24 M | -2.89% | 2.15% |
| RTW INVESTMENTS, LP | 02/14/2025 | 1.97 M | $82.79 M | 0.00% | 2.06% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 1.74 M | $73.19 M | -12.05% | 1.82% |
| INVESCO LTD. | 02/13/2025 | 1.70 M | $71.51 M | 1.52% | 1.78% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 1.69 M | $71.23 M | 0.24% | 1.77% |
| ALKEON CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.69 M | $70.96 M | -43.99% | 1.77% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 1.63 M | $68.49 M | 5.28% | 1.70% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 1.58 M | $66.31 M | 0.00% | 1.65% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.56 M | $65.77 M | -0.53% | 1.64% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 1.50 M | $63.11 M | 100.00% | 1.57% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 1.44 M | $60.57 M | 23.05% | 1.51% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 1.18 M | $49.77 M | -22.46% | 1.24% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 1.18 M | $49.76 M | 80.96% | 1.24% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 1.17 M | $49.37 M | 125.46% | 1.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.15 M | $48.44 M | 0.00% | 1.21% |
| MARSHALL WACE, LLP | 02/13/2025 | 1.05 M | $44.24 M | 27.93% | 1.10% |
| NORGES BANK | 02/12/2025 | 961,794 | $40.46 M | 100.00% | 1.01% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/12/2025 | 958,077 | $40.31 M | 32.30% | 1.00% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 913,500 | $38.43 M | -7.52% | 0.96% |
| AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 830,000 | $34.92 M | 0.00% | 0.87% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 829,465 | $34.90 M | 5.81% | 0.87% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 02/14/2025 | 763,607 | $32.12 M | 1.13% | 0.80% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 747,429 | $31.44 M | 86.47% | 0.78% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 738,973 | $31.09 M | -4.29% | 0.77% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 697,236 | $29.33 M | -1.89% | 0.73% |
| CANDRIAM S.C.A. | 02/07/2025 | 674,257 | $28.37 M | -5.45% | 0.71% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 658,715 | $27.71 M | 3.95% | 0.69% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 653,513 | $27.49 M | 100.00% | 0.68% |
| EAGLE HEALTH INVESTMENTS LP | 02/12/2025 | 627,600 | $26.40 M | 11.73% | 0.66% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 614,948 | $25.87 M | -18.62% | 0.64% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 613,633 | $25.82 M | 3.21% | 0.64% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 553,670 | $23.29 M | 9.31% | 0.58% |
| FIRST TRUST ADVISORS LP | 02/13/2025 | 544,202 | $22.89 M | 3,097.05% | 0.57% |
| EMERALD ADVISERS, LLC | 02/11/2025 | 518,328 | $21.81 M | -9.03% | 0.54% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/05/2025 | 509,545 | $21.44 M | 9.21% | 0.53% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 02/12/2025 | 500,717 | $21.07 M | -7.68% | 0.52% |
| FRED ALGER MANAGEMENT, LLC | 02/14/2025 | 466,265 | $19.62 M | -13.06% | 0.49% |
| AXA S.A. | 02/14/2025 | 456,588 | $19.21 M | 7.33% | 0.48% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 427,359 | $17.98 M | 95.23% | 0.45% |
| CUTTER CAPITAL MANAGEMENT, LP | 02/14/2025 | 406,803 | $17.11 M | 41.84% | 0.43% |
| FMR LLC | 02/13/2025 | 395,984 | $16.66 M | -37.92% | 0.41% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 391,018 | $16.45 M | 18.59% | 0.41% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 388,661 | $16.35 M | -1.04% | 0.41% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 377,500 | $15.88 M | 93.59% | 0.40% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ultragenyx Pharmaceutical Inc. institutional Ownership - FAQ's
During the previous two years, 410 institutional investors and hedge funds held shares of Ultragenyx Pharmaceutical Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 10.03 M
BlackRock Funding, Inc. /DE: 6.54 M
SANDS CAPITAL MANAGEMENT, LLC: 4.3 M
PRICE T ROWE ASSOCIATES INC /MD/: 2.51 M
WELLINGTON MANAGEMENT GROUP LLP: 2.46 M
Clearbridge Investments, LLC: 2.32 M
91.64% of Ultragenyx Pharmaceutical Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 97.97 M shares in the last 24 months. This purchase volume represents approximately $4.18 B in transactions.